non branded semaglutide There's still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming Novo Nordisk medicines containing semaglutide

Rozenberg GI, Monahan KB, Torrice C, Bear JE, Sharpless NE

Main outcome parameters and results: The main efficacy parameter was the effect of treatment on 6- and 12-month changes from baseline in nerve conduction velocity (NCV) and amplitude in the sensory (ulnar, sural and median) and motor (median, ulnar and peroneal) nerves

Semaglutide injections target the GLP-1 receptor, while tirzepatide injections activate both GLP-1 and GIP

For example, policies with in-patient-only benefits would be expected to have limited exposure to GLP-1 utilization because these drugs are mainly prescribed in the outpatient setting

2018;155(4):1661-9.e4